Literature DB >> 35907178

Developing an Online Infrastructure to Enhance Model Accessibility and Validation: The Peer Models Network.

Stephanie Harvard1, Amin Adibi2, Adam Easterbrook3, Gregory R Werker3,4, David Murphy5, Don Grant6, Alison Mclean6, Zhina Majdzadeh2, Mohsen Sadatsafavi2.   

Abstract

Entities:  

Mesh：

Year:  2022        PMID： 35907178     DOI： 10.1007/s40273-022-01179-x

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN： 1170-7690            Impact factor:   4.558


× No keyword cloud information.
  12 in total

1.  Social, ethical, and other value judgments in health economics modelling.

Authors:  Stephanie Harvard; Gregory R Werker; Diego S Silva
Journal:  Soc Sci Med       Date:  2020-04-02       Impact factor: 4.634

Review 2.  Transparency in Decision Modelling: What, Why, Who and How?

Authors:  Christopher James Sampson; Renée Arnold; Stirling Bryan; Philip Clarke; Sean Ekins; Anthony Hatswell; Neil Hawkins; Sue Langham; Deborah Marshall; Mohsen Sadatsafavi; Will Sullivan; Edward C F Wilson; Tim Wrightson
Journal:  Pharmacoeconomics       Date:  2019-11       Impact factor: 4.981

3.  Four Aspects Affecting Health Economic Decision Models and Their Validation.

Authors:  Talitha Feenstra; Isaac Corro-Ramos; Dominique Hamerlijnck; George van Voorn; Salah Ghabri
Journal:  Pharmacoeconomics       Date:  2021-12-16       Impact factor: 4.981

4.  Putting Stakeholder Engagement at the Center of Health Economic Modeling for Health Technology Assessment in the United States.

Authors:  Richard Z Xie; Erica deFur Malik; Mark T Linthicum; Jennifer L Bright
Journal:  Pharmacoeconomics       Date:  2021-05-13       Impact factor: 4.981

5.  Developing a Framework for Public Involvement in Mathematical and Economic Modelling: Bringing New Dynamism to Vaccination Policy Recommendations.

Authors:  Sophie Staniszewska; Edward M Hill; Richard Grant; Peter Grove; Jarina Porter; Tinevimbo Shiri; Sue Tulip; Jane Whitehurst; Claire Wright; Samik Datta; Stavros Petrou; Matt Keeling
Journal:  Patient       Date:  2021-01-19       Impact factor: 3.883

6.  Health Economists on Involving Patients in Modeling: Potential Benefits, Harms, and Variables of Interest.

Authors:  Stephanie Harvard; Gregory R Werker
Journal:  Pharmacoeconomics       Date:  2021-05-07       Impact factor: 4.981

7.  Model Registration: A Call to Action.

Authors:  Christopher James Sampson; Tim Wrightson
Journal:  Pharmacoecon Open       Date:  2017-06

8.  Achieving Appropriate Model Transparency: Challenges and Potential Solutions for Making Value-Based Decisions in the United States.

Authors:  Josh J Carlson; Surrey M Walton; Anirban Basu; Richard H Chapman; Jonathan D Campbell; R Brett McQueen; Steven D Pearson; Daniel R Touchette; David Veenstra; Melanie D Whittington; Daniel A Ollendorf
Journal:  Pharmacoeconomics       Date:  2019-11       Impact factor: 4.981

9.  The Challenge of Transparency and Validation in Health Economic Decision Modelling: A View from Mount Hood.

Authors:  Seamus Kent; Frauke Becker; Talitha Feenstra; An Tran-Duy; Iryna Schlackow; Michelle Tew; Ping Zhang; Wen Ye; Shi Lizheng; William Herman; Phil McEwan; Wendelin Schramm; Alastair Gray; Jose Leal; Mark Lamotte; Michael Willis; Andrew J Palmer; Philip Clarke
Journal:  Pharmacoeconomics       Date:  2019-11       Impact factor: 4.981

10.  Developing Open-Source Models for the US Health System: Practical Experiences and Challenges to Date with the Open-Source Value Project.

Authors:  Jeroen P Jansen; Devin Incerti; Mark T Linthicum
Journal:  Pharmacoeconomics       Date:  2019-11       Impact factor: 4.981
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.